Abstract:OBJECTIVE:To study the ectopic osteogenesis and vascularization of the tissue engineered bone promoted by an artificial bone composite that consists of coral hydroxyapatite (CHA), 1,25-(OH)2D3, human marrow stromal osteoblast (hMSO), and human umbilical vein endothelial cell (hUVEC).METHODS:After the isolation and the culture in vitro, hMSO and hUVEC were obtained. Then, hMSO (5 x 10(5)/ml) and hUVEC (2.5 x 10(5)/ml) were seeded at a ratio of 2 : 1 onto the CHA scaffolds coated with 1,25-(OH)2D3 (the experimental group) or onto the CHA scaffolds without 1,25-(OH)2D3 (the control group). The scaffolds were cultured in vitro for 3 days, and then the scaffolds were implanted into the pockets that had been made on the backs of 18 nude mice. Then, 6 of the mice were implanted with one experimental engineered bone bilaterally; another 6 mice were implanted with one control engineered bone bilaterally; the remaining 6 mice were implanted with one experimental engineered bone and one control engineered bone on each side. At 4, 8 and 12 weeks after operation, the retrieved scaffolds and cells were examined by the nake eye and histology as well as by the scanning electron microscopy. The quantitative assessment of the newly-formed bone and the quantitative analysis of the newly-formed blood vessels were performed.RESULTS:The evaluations by the histology revealed that at 4 weeks the original bone tissues grew into the scaffolds in all the groups, but significantly more newly-formed bone tissues and newly-formed blood vessels were found in the experimental group. At 12 weeks the newly-formed bone tissues were found in all the groups, but there was a typical bone unit found in the experimental group. There was a significantly smaller amount of capillary vessels in the control group than in the experimental group at all the time points. The evaluations by the scanning electron microscopy revealed that at 4 weeks in the experimental group there were great amounts of extracelluar matrix that embedded the cells, and plenty of capillary vessels were found on the surface of the implanted bone materials and some of them grew into the materials; however, in the control group there was a smaller amount of capillary vessels although much extracelluar matrix was still found there. At 8 weeks sarciniform osteoids were found on some of the implanted materials, with much extracelluar matrix and many newly-formed capillary vessels in the experimental group; however, in the control group there were fewer capillary vessels and lower degrees of the bone maturity. The quantitative assessment of the newly-formed bone showed that the new-formed bones were 3.1 +/- 0.52 in the experimental group but 2.30 +/- 0.59 in the control group at 8 weeks (P < 0.05), and 4.63 +/- 0.55 vs. 3.53 +/- 0.62 at 12 weeks. There was a significant difference at these two time points between the two groups (P < 0.05). The quantitative analysis of the newly-formed blood vessels showed that the vascular areas were 28.74% +/- 7.81% in the experimental group but 19.52% +/- 4.57% in the control group at 4 weeks (P < 0.05), and 24.66% +/- 7.38% vs. 17.84% +/- 5.22% at 12 weeks. There was a significant difference at these two time points between the two groups (P < 0.05).CONCLUSION:1,25-(OH)2D3 as an active factor can increase the interaction between hMSO and hUVEC, and thus promote the ectopic osteogenesis and vascularization in the tissue engineered bone.

Influence of vascular endothelial growth factor on osteogenesis of coral bone substitute

VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute

Rabbits Bone Marrow Stromal Cells Enhauce Angiogenesis and Osteogenesis

Effect of Vascular Endothelial Cell Growth Factor on Repair of Bone Defect with Cortical Bone Allograft

Bone Marrow Stromal Cells with A Combined Expression of Bmp-2 and Vegf-165 Enhanced Bone Regeneration

VEGF Gene Transfected Human BMSCs Acting as Seeding Cell for Tissue Engineering Bond in Orbital Wall Bone Defects

Exogenous VEGF Introduced by Bioceramic Composite Materials Promotes the Restoration of Bone Defect in Rabbits

Repairing bone defects with vascular endothelial growth factor/nano-hydroxyapatite composite artificial bone

Expression of Vascular Endothelial Growth Factor in Repair of Cranial Bone Defect with Acellular Bone Matrix Combined with Platelet-Rich Plasma

Modified Approach to Construct a Vascularized Coral Bone in Rabbit Using an Arteriovenous Loop.

Effects of Vascular Endothelial Growth Factor for Repairing Bone Defect

1,25-(OH)2VitD3 promotes osteogenesis and vascularization of tissue-engineered bone

Transfect Bone Marrow Stromal Cells with Pcdna3.1-Vegf to Construct Tissue Engineered Bone in Defect Repair

Inoculation of marrow derived osteoblasts to ectopia osteogenesis in coral granules

Applying of Vascular Endothelial Growth Factor(vegf) in the Vascularizing Process of Artificial Bone

Effect of calcium phosphate cement/bone morphogenetic protein 6/vascular endothelial growth factor in bone defect repair

Rhvegf 165 Delivered in a Porous Beta-Tricalcium Phosphate Scaffold Accelerates Bridging of Critical-Sized Defects in Rabbit Radii.

[Experimental study of calcium phosphate cement mixed with bFGF and VEGF to repair bone defects in rabbit radius].

Comparative Study Between Coral-Mesenchymal Stem Cells-Rhbmp-2 Composite And Auto-Bone-Graft In Rabbit Critical-Sized Cranial Defect Model

Treatment of rabbit femoral head necrosis with polylactic acid/hydroxyapatite porous scaffold combined with rabbit bone marrow mesenchymal stem cells transfected by vascular endothelial growth factor

[A Research on Ectopic Osteogenesis and Vascularization of Tissue Engineered Bone Promoted by 1,25-(OH)2D3].